跳至主要内容
临床试验/NCT03457883
NCT03457883已完成不适用

Risk Factors for Recurrence After Pelvic Reconstruction of Pelvic Organ Prolapse:1 Year Follow-up in Patients Implanted Hernia Mesh and Biological Graft

Nanjing Medical University0 个研究点目标入组 232 人开始时间: 2015年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
232
主要终点
recurrence

研究概览

简要总结

232 women underwent transvaginal mesh repair (TVM)with /without transvaginal hysterectomy for symptomatic POP, including group A(accepted herniamesh polypropylene mesh, 117 patients);group B (underwent biological graft of cook,115 patients);follow-ups for six months and one year after the surgery and a questionnaire about the life habits associated with relapse.

详细描述

We prospectively study a total of 232 women who underwent transvaginal mesh repair (TVM)with /without transvaginal hysterectomy for symptomatic POP, the patients into two groups :group A was accepted herniamesh polypropylene mesh(117);group B underwent biological graft of cook(115);Each patient underwent an interview that included a POP-Q which was quantified according to the Pelvic Organ Prolapse Quantitation (POPQ) system;follow-ups for six months and one year after the surgery and a questionnaire about the life habits associated with relapse.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Double (Participant, Investigator)

入排标准

年龄范围
52 Years 至 76 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • 242 postmenopausal patients with primary prolapse of the anterior vaginal wall or concomitant uterine prolapse,that was stage Ⅲ or higher (according to the Pelvic Organ Prolapse Quantification [POP-Q] system).

排除标准

  • pelvic floor repair surgery history and recurrent patients ; pelvic cancer and radiation to the pelvic area in the previous 6 months; simple uterine prolapse; combined with severe stress urinary incontinence or overactive bladder (OAB); local or systemic conditions that would preclude surgery or affect healing such as restricted leg motion (inability to conform to the lithotomy position) ; vaginal bleeding; infection; coagulation disorders; uncontrolled hypertension and diabetes mellitus;

研究组 & 干预措施

group A

Experimental

accepted herniamesh mesh

干预措施: herniamesh (Device)

group B

Experimental

accepted biological graft of cook

干预措施: biological graft (Device)

结局指标

主要结局

recurrence

时间窗: at 12 months after surgery

Recurrence was defined as a POP-quantification system stage ≥IIb or any symptomatic prolapse.

次要结局

  • perioperative complications(12 months after surgery)

研究者

发起方
Nanjing Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Xirong Guo

Vice President of Nanjing maternity and child Health Care Hospital

Nanjing Medical University

相似试验